Argus
Changshahsien
About Argus
Argus is a pharmaceutical company with a concentration on biological fermentation, extraction intermediates, raw materials, and formulations. It possesses internationally advanced technology in the fields of microbial fermentation, macromolecular protein expression, and special synthesis. The business operates a large-scale microbial fermentation workshop, a line for producing drugs from raw materials, and an entire drug packaging workplace. With a robust production capacity and an extensive quality system, the company's production adheres to GMP laws and ensures product quality and delivery time.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $4.9M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2017)
- Website: arguspharms.com
- Phone: +86 731-8555-7699
Industries & Categories
Biopharma, Biotechnology, Medical
Canonical: https://fsome.com/organization/argus-34290 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.